How to Achieve a Higher Pathologic Complete Response in Patients With Locally Advanced Rectal Cancer Who Receive Preoperative Chemoradiation Therapy

다국어 초록 (Multilingual Abstract)

The current standard of care for treating patients with locally advanced rectal cancer includes preoperative chemoradiation therapy (PCRT) followed by a total mesorectal excision and postoperative adjuvant chemotherapy. A subset of these patients has achieved a pathologic complete response (pCR) and they have shown improved disease-free and overall survival compared to non-pCR patients. Thus, many efforts have been made to achieve a higher pCR through PCRT. In this review, results from various ongoing and recently completed clinical trials that are being or have been conducted with an aim to improve tumor response by modifying therapy will be discussed.

참고문헌 (Reference)

1 Dinaux AM, "The impact of pathologic complete response in patients with neoadjuvantly treated locally advanced rectal cancer-a large single-center experience" 21 : 1153-1158, 2017

2 Peeters KC, "The TME trial after a median follow-up of 6 years : increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma" 246 : 693-701, 2007

3 Rouanet P, "Tailored treatment strategy for locally advanced rectal carcinoma based on the tumor response to induction chemotherapy : preliminary results of the French phase II multicenter GRECCAR4 trial" 60 : 653-663, 2017

4 Marechal R, "Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer : a randomized multicentric phase II study" 23 : 1525-1530, 2012

5 Evans J, "Results of a prospective randomised control 6 vs 12 trial: is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?" 27 (27): 4520-, 2016

6 National Comprehensive Cancer Network, "Rectal cancer (version 3. 2018)" National Comprehensive Cancer Network

7 Aschele C, "Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer : pathologic results of the STAR-01 randomized phase III trial" 29 : 2773-2780, 2011

8 Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer" 351 : 1731-1740, 2004

9 Gerard JP, "Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers : results of FFCD 9203" 24 : 4620-4625, 2006

10 Sebag-Montefiore D, "Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer(MRC CR07 and NCIC-CTG C016) : a multicentre, randomised trial" 373 : 811-820, 2009

11 Rodel C, "Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer : initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial" 13 : 679-687, 2012

12 Fernandez-Martos C, "Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin(CAPOX)compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer : Grupo cancer de recto 3 study" 28 : 859-865, 2010

13 Dellas K, "Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer" 8 : 90-, 2013

14 Lorimer PD, "Pathologic complete response rates after neoadjuvant treatment in rectal cancer : an analysis of the National Cancer Database" 24 : 2095-2103, 2017

15 Rodel C, "Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer(the German CAO/ARO/AIO-04 study) : final results of the multicentre, open-label, randomised, phase 3 trial" 16 : 979-989, 2015

16 Sainato A, "No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum(LARC) : long term results of a randomized trial(I-CNR-RT)" 113 : 223-229, 2014

17 Gao YH, "Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer : a prospective phase 2 trial" 90 : 1153-1160, 2014

18 Chua YJ, "Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer : a phase 2 trial" 11 : 241-248, 2010

19 Allegra CJ, "Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial" 107 : 2015

20 Dewdney A, "Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer(EXPERT-C)" 30 : 1620-1627, 2012

21 Deng Y, "Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer : initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial" 34 : 3300-3307, 2016

22 Gormly KL, "MRI rectal cancer in Australia and New Zealand : an audit from the PETACC-6 trial" 60 : 607-615, 2016

23 van der Valk MJM, "Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database(IWWD) : an international multicentre registry study" 391 : 2537-2545, 2018

24 Maas M, "Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer : a pooled analysis of individual patient data" 11 : 835-844, 2010

25 Bujko K, "Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer : results of a randomized phase III study" 27 : 834-842, 2016

26 Francois Y, "Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer : the Lyon R90-01 randomized trial" 17 : 2396-, 1999

27 Schou JV, "Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer" 23 : 2627-2633, 2012

28 Petrelli F, "Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer : a meta-analysis of published studies" 263 : 458-464, 2016

29 Swedish Rectal Cancer Trial, "Improved survival with preoperative radiotherapy in resectable rectal cancer" 336 : 980-987, 1997

30 Gerard JP, "Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy : the lyon R96-02 randomized trial" 22 : 2404-2409, 2004

31 Emmertsen KJ, "Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer" 100 : 1377-1387, 2013

32 Vuong T, "High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer" 7 : 183-188, 2015

33 Buckley H, "High-dose-rate brachytherapy in the management of operable rectal cancer : a systematic review" 99 : 111-127, 2017

34 Appelt AL, "High-dose chemoradiotherapy and watchful waiting for distal rectal cancer : a prospective observational study" 16 : 919-927, 2015

35 Krook JE, "Effective surgical adjuvant therapy for high-risk rectal carcinoma" 324 : 709-715, 1991

36 Lefevre JH, "Effect of interval(7 or 11 weeks)between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer : a multicenter, randomized, controlled trial(GRECCAR-6)" 34 : 3773-3780, 2016

37 Garcia-Aguilar J, "Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer : a multicentre, phase 2 trial" 16 : 957-966, 2015

38 Marco MR, "Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer : final results of a multicenter phase II trial" 61 : 1146-1155, 2018

39 Perez K, "Complete neoadjuvant treatment for rectal cancer : the Brown University Oncology Group CONTRE Study" 40 : 283-287, 2017

40 Gerard JP, "Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer : results of the phase III trial ACCORD 12/0405-Prodige 2" 28 : 1638-1644, 2010

41 Gerard JP, "Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer" 30 : 4558-4565, 2012

42 Glynne-Jones R, "Chronicle : results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin(XELOX)versus control" 25 : 1356-1362, 2014

43 Bosset JF, "Chemotherapy with preoperative radiotherapy in rectal cancer" 355 : 1114-1123, 2006

44 O’Connell MJ, "Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer : surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04" 32 : 1927-1934, 2014

45 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015" 대한암학회 50 (50): 303-316, 2018

46 Breugom AJ, "Adjuvant chemotherapy for rectal cancer patients treated with preoperative(chemo)radiotherapy and total mesorectal excision : a Dutch Colorectal Cancer Group(DCCG)randomized phase III trial" 26 : 696-701, 2015

47 Breugom AJ, "Adjuvant chemotherapy after preoperative(chemo)radiotherapy and surgery for patients with rectal cancer : a systematic review and meta-analysis of individual patient data" 16 : 200-207, 2015

48 Nogue M, "Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer : the AVACROSS study" 16 : 614-620, 2011

49 Kim SY, "A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer : KCSG CO 14-03" 101 : 889-899, 2018

50 Garcia-Aguilar J, "A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision" 46 : 298-304, 2003